AI-generated summary
The authors report a single-institution pilot study in which 33 patients receiving 60 Gy or higher to the neck were given photobiomodulation therapy during radiation. They reported high treatment completion and no significant side effects, with 39% developing wet desquamation and 9% grade 3 toxicity. The authors state that a randomized trial is needed to establish efficacy.
- Participants
- 33
- Who or what was studied
- Patients scheduled to receive 60 Gy or higher radiation dose to the neck for head and neck cancer or lung cancer with supraclavicular lymph node metastasis
- Limits stated in the abstract
- The abstract describes a single-institution pilot study without a control group, so efficacy cannot be established and the authors call for a randomized trial.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Pilot study, Photobiomodulation therapy, Dose, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.